Wells Fargo’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
EAM
GCP
BGM
Wells Fargo's TNYA Position: Q2 2026 in Review
Wells Fargo held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 2,000 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #6402.
Wells Fargo first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $354K in Q4 2021. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.
- Wells Fargo held 2,000 shares of Tenaya Therapeutics worth $1.48K as of Q2 2026.
- Wells Fargo left its Tenaya Therapeutics share count unchanged in Q2 2026.
- Tenaya Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6402 holding.
- Wells Fargo first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
- Wells Fargo's Tenaya Therapeutics position peaked at $354K in Q4 2021.
- 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.